Group 1 - The core viewpoint of the news is that Prasis has experienced a decline in stock performance and financial metrics, indicating potential challenges in its business operations [1][2]. - On October 9, Prasis' stock price fell by 1.56%, with a trading volume of 85.11 million yuan. The financing buy-in amount was 7.47 million yuan, while the financing repayment was 7.84 million yuan, resulting in a net financing buy-in of -0.37 million yuan [1]. - As of October 9, the total margin balance for Prasis was 54.37 million yuan, which accounts for 1.46% of its market capitalization, indicating a low financing balance compared to the past year [1]. Group 2 - As of August 29, the number of shareholders for Prasis was 8,571, a decrease of 1.88% from the previous period, while the average circulating shares per person increased by 1.91% to 8,787 shares [2]. - For the first half of 2025, Prasis reported a revenue of 390 million yuan, a year-on-year decrease of 1.08%, and a net profit attributable to shareholders of 54.16 million yuan, down 1.40% year-on-year [2]. - Since its A-share listing, Prasis has distributed a total of 40.77 million yuan in dividends [3]. Group 3 - As of June 30, 2025, among the top ten circulating shareholders of Prasis, Tianhong Medical Health A held 1.43 million shares, a decrease of 17,600 shares from the previous period, while Rongtong Health Industry Flexible Allocation Mixed A/B increased its holdings by 100,000 shares to 1 million shares [3]. - Jin Ying Medical Health Stock A has exited the list of the top ten circulating shareholders [3].
普蕊斯10月9日获融资买入746.76万元，融资余额5437.39万元